Vectobac 12 AS
Primær information
- Handelsnavn:
- Vectobac 12 AS Flydende middel
- Aktiv bestanddel:
- H14
- Tilgængelig fra:
- Cillus A/S
- INN (International Name):
- H14
- Lægemiddelform:
- Flydende middel
- Sammensætning:
- 1200 ITU/mg Bacilus thuringiensis var. H14
- Brugt til:
- Planter
- Medicin typen:
- agrokemiske
Dokumenter
- for sundhedspersonale:
- Produktresumé
-
- for den brede offentlighed:
- Oplysningerne indlægssedlen for dette produkt er i øjeblikket ikke tilgængelig, kan du sende en anmodning til vores kundeservice, og vi vil give dig besked, så snart vi er i stand til at opnå det.
Anmode informationsbrochure for offentligheden.
Lokation
- Fås i:
-
Danmark
- Sprog:
- dansk
Andre oplysninger
Status
- Kilde:
- SEGES Landbrug & Fødevarer
- Autorisation status:
- Udgået
- Autorisationsnummer:
- Ingen afstandskrav.
- Sidste ændring:
- 23-07-2018
Produktresumé
LEVERANDØRBRUGSANVISNING
(Sikkerhedsdatablad)
Udarbejdet efter Arbejdsministeriets bekendtgørelse nr 485 af 16. juni 1995 om stoffer og materialer, § 16, stk. 2.
VECTOBAC
12AS
1. Produktidentifikation
VECTOBAC
12AS
Produkttype:
Biologisk insektmiddel til bekæmpelse
af larver på planter
Leverandør:
Cillus A/S
Tlf.: 4491 6055
Kobbervej 8
Fax.: 4491 6575
2730
Herlev
Kontaktperson: E. Rubæk
2. Oplysning om indholdsstoffer:
Analyse:
VECTOBAC
12AS indeholder 1200
International Toxic Units pr. mg
(1,25%) af Bacillus thuringiensis H-14.
Resten inaktive fyldstoffer (98,75%).
3. Faredeklaration
For mennesker: Undgå kontakt med huden og øjnene.
4. Førstehjælp
Øjne:
Kommer stoffet i øjnene, skylles straks
med vand og læge kontaktes.
Hud:
Forurenet tøj fjernes straks, og forure-
net hud vaskes straks med vand og
sæbe.
Indånding:
Søg frisk luft og hvile
Indtagelse:
Skyl munden, drik rigeligt vand og søg
læge.
Forbrænding:
Ikke brændbart.
5. Forholdsregler ved brand
Produktet bør så vidt muligt fjernes fra brandstedet.
Sluk med pulver, skum eller vandtåge. Hold emballa-
gerne afkølet ved oversprøjtning med vand, hvis udsat
for stærk varme. Undgå indånding af røg og gasser, der
udvikles ved branden.
6. Forholdsregler ved spild
Må ikke hældes i afløb, vandløb eller på jorden.
Evt. spild opsamles med væskeabsorberende materiale,
og dette skal sammen med tom emballage og rester af-
leveres til den kommunale modtageordning.
7. Håndtering og opbevaring
Undgå spild. Brug ansigtsskærm eller beskyttelsesbril-
ler, handsker og forklæde ved udsprøjtning.
S2 -Opbevares utilgængeligt for børn.
S13 -Må ikke opbevares sammen med fødevarer, drik-
kevarer og foderstoffer.
8. Eksponeringskontrol/Personlige værnemidler
Undgå indånding af sprøjtetågen
Undgå kontakt med huden
Brug beskyttelseshandsker. Flerlagshandsker bør fore-
trækkes. Tilsmudset tøj skiftes straks.
Vask huden efter arbejdet.
Efter sprøjtning skal planterne være tørre på bladene,
inden håndtering påbegyndes.
Følg i øvrigt Arbejdstilsynets vejledning og regler om
arbejdstøj og personlige værnemidler.
9. Fysisk-kemiske egenskaber
Tilstandsform:
Vandig suspension
Farve:
Lysebrun
Lugt:
Fermenteringsagtig
Kogepunkt:
Frysepunkt:
Flammepunkt:
ikke brændbart
Opløselighed
i vand:
Opslemning
Vægtfylde:
1,05
ca. 5
10. Stabilitet og reaktivitet
Produktet er lagerfast i mindst 2 år i uåbnet emballage.
Undgå store temperaturudsving. Undgå direkte sollys.
11. Toksikologiske oplysninger
Akut LD-50:
Ved indtagelse > 5000 mg/kg
Ved hudkontakt > 5000 mg/kg
Akut LC-50:
Ved inhalering >5,34 mg/l
Indånding:
Kan give svag irritation.
Hudkontakt:
Kan give svag irritation ved langvarig
påvirkning.
Øjnene:
Stænk i øjnene giver svag irritation
(sviden)
VECTOBAC
12AS
29.04.04
Side 2 af 2
12. Miljøoplysninger
Såvel B.t. som fyldstofferne anses for ikke særlig ska-
delig for miljøet. Se i øvrigt punkt 6.
13. Bortskaffelse
Tom emballage må ikke genanvendes til andet formål.
Tom emballage og rester afleveres til den kommunale
modtageordning.
Rengjort emballage afleveres som dagrenovation.
14. Transportoplysninger
VECTOBAC
12AS er ikke underlagt ADR, hvorfor
der ikke er specielle regler for tranport.
15. Forholdsregler ved brug:
Opbevaring:
VECTOBAC
12AS opbevares frost-
frit.
Må ikke stå i direkte sollys.
Holdbar i uåbnet emballage i mindst 2
år.
Emballagen omrystes grundigt inden det afmålte
kvantum hældes i sprøjtebeholderen under moderat
omrøring.
Tømt og skyllet emballage bortskaffes med dagre-
novationen.
Kommer væsken i øjnene, skyl da omgående med
rigeligt vand
Undgå indånding af sprøjtevæsken.
Anvend ansigtsskærm, handsker og forklæde ved
udsprøjtning.
Planterne skal være tørre inden håndtering påbe-
gyndes.
Vask sprøjteudstyret straks efter arbejdets ophør.
Der kræves ingen særlig uddannelse, dog må unge
under 18 år ikke arbejde med produktet.
16. Brugsanvisning
VECTOBAC
12AS er et biologisk bekæmpelses-
middel, der anvendes mod larver af sørgemyg
(svampemyg) i væksthuse, samt filterfluer (møg-
fluer) i rensningsanlæg og stankelbenlarver på
græsarealer.
"
VECTOBAC
12AS anvendes erhvervsmæssigt
eller privat efter behov.
"
Der er ingen behandlingsfrist. Vask hænder og ud-
styr efter endt udsprøjtning.
"
VECTOBAC
12AS sprøjtevandes på borde, i
potter og på jorden under bordene. Der vandes så
de øverste 3-4 cm af voksemediet er gennemvædet
-ca 2 ltr. væske pr m
. Gennemvanding bør have
fundet sted, inden sprøjtevanding -ikke omvendt.
"
VECTOBAC
12AS optages af sørgemyggens
larver i jorden. Efter 1-2 dages forløb standser lar-
verne fødeoptagelsen og dør.
"
Doseringen er 0,125 - 0,25% styrke i 2 ltr. vand pr.
. Svarende til, at der anvendes 2½ - 5 ml
VECTOBAC
12AS pr m
. 1 ltr. VECTOBAC
12AS rækker således til 200 - 400 m
behandlet
areal.
"
Første behandling umiddelbart efter oppotning.
Behandlingen gentages med 5 - 7 dages interval, i
alt 3 gange. Brug gule limplader til at kontrollere
om flyvningen er holdt op. VECTOBAC
12AS
kan sprøjtevandes sammen med nematoder.
"
VECTOBAC
12AS må ikke blandes med gød-
ning eller lign., der kan neutralisere virkningen -
hverken ved tankblanding eller drypvanding.
Tålsomhed:
Mange plantearter har været prøvet
uden skade, når doseringen overholdes.
Når der skiftes fra en art/sort til en an-
den, eller kulturbetingelserne ændres,
anbefales det at prøve få planter, inden
et helt parti behandles.
VECTOBAC
12AS er anerkendt af
Danmarks Jordbrugsforskning til be-
handling mod larver af sørgemyg på
prydplanter i væksthus med 5 ml pr m
2
Larver af mosestankelben på græsarealer kan være et
problem. Især hvis der året efter skal sås andre afgrø-
der. En total bekæmpelse af mosestankelben er ikke
mulig, men en væsentlig reduktion af larvebestanden
kan forventes.
Tidspunkt:
I oktober måned vælges en mild og fugtig dag. Sprøjt
sidst på dagen når larverne kommer op til overfladen
for at æde af planterne.
Dosering:
2 -2½ ltr. VECTOBAC
12AS pr. ha i mindst 400 ltr.
vand, gerne mere. Evt. i let regnvejr.
Genbehandling:
Hvis klækning af larver sker over en lang periode, kan
behandlingen gentages - evt. næste forår, fortsat med
stor fugtighed i jordoverfladen og gerne i let regn.
Læs mere om bekæmpelse af mosestankelben i ”Mar-
kens sygdomme og skadedyr”.
Udarbejdet af E. Rubæk den 29.04.2004
- Oplysningerne indlægssedlen for dette produkt er i øjeblikket ikke tilgængelig, kan du sende en anmodning til vores kundeservice, og vi vil give dig besked, så snart vi er i stand til at opnå det.
Anmode informationsbrochure for offentligheden.
Dokumenter på andre sprog er tilgængelige her
- Adgang til dette dokument er kun tilgængelig for registrerede brugere.
Tilmeld dig nu for fuld adgang
5-10-2018
Consumer Alert: Sprout Creek Farm “Margie” Cheese Batch Recalled
Today the New York State Department of Agriculture and Markets alerted consumers to a pasteurization problem with one of Sprout Creek Farm's pasteurized cow's milk cheeses, "Margie," made on 8/28/2018. Sprout Creek Farm is located in Poughkeepsie, NY. The reason for the recall is the air temperature at the start and end of the pasteurization process is required to be above 150deg F per the Grade "A" Pasteurized Milk Ordinance; the batch in question did not meet that standard. The recall pertains only to...
FDA - U.S. Food and Drug Administration
2-10-2018
Review of the existing maximum residue levels for cyflufenamid according to Article 12 of Regulation (EC) No 396/2005
Published on: Mon, 01 Oct 2018 00:00:00 +0200 According to Article 12 of Regulation (EC) No 396/2005, EFSA has reviewed the maximum residue levels (MRLs) currently established at European level for the pesticide active substance cyflufenamid. To assess the occurrence of cyflufenamid residues in plants, processed commodities, rotational crops and livestock, EFSA considered the conclusions derived in the framework of Directive 91/414/EEC as well as the European authorisations reported by Member States (in...
Europe - EFSA - European Food Safety Authority Publications
27-9-2018
Review of the existing maximum residue levels for tembotrione according to Article 12 of Regulation (EC) No 396/2005
Published on: Wed, 26 Sep 2018 00:00:00 +0200 According to Article 12 of Regulation (EC) No 396/2005, EFSA has reviewed the maximum residue levels (MRLs) currently established at European level for the pesticide active substance tembotrione. To assess the occurrence of tembotrione residues in plants, processed commodities, rotational crops and livestock, EFSA considered the conclusions derived in the framework of Commission Regulation (EU) No 188/2011 as well as the import tolerances and European author...
Europe - EFSA - European Food Safety Authority Publications
24-9-2018
FDA awards 12 grants to fund new clinical trials to advance the development of medical products for the treatment of rare diseases
FDA has awarded 12 new clinical trial research grants to enhance the development of medical products for patients with rare diseases
FDA - U.S. Food and Drug Administration
14-9-2018
Human medicines European public assessment report (EPAR): Abilify Maintena, aripiprazole, Revision: 12, Authorised
Europe - EMA - European Medicines Agency
13-9-2018
Human medicines European public assessment report (EPAR): Cometriq, cabozantinib, Revision: 12, Authorised
Europe - EMA - European Medicines Agency
13-9-2018
Review of the existing maximum residue levels for fluquinconazole according to Article 12 of Regulation (EC) No 396/2005
Published on: Wed, 12 Sep 2018 00:00:00 +0200 According to Article 12 of Regulation (EC) No 396/2005, EFSA has reviewed the maximum residue levels (MRLs) currently established at European level for the pesticide active substance fluquinconazole. Considering the information provided by Member States, neither EU uses nor import tolerances are currently authorised for fluquinconazole within the European Union. Furthermore, no MRLs are established by the Codex Alimentarius Commission (codex maximum residue ...
Europe - EFSA - European Food Safety Authority Publications
12-9-2018
Enforcement Report for the Week of September 12, 2018
Recently Updated Records for the Week of September 12, 2018 Last Modified Date: Friday, September 07, 2018
FDA - U.S. Food and Drug Administration
7-9-2018
Camber Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Montelukast Tablets USP, 10mg 30Ct. due to Product/Label Mix-Up
Camber Pharmaceuticals, Inc. is voluntarily recalling one single lot of Montelukast Sodium Tablets, USP 10mg, to the consumer level. This recall of one batch of Montelukast Sodium Tablets, USP 10mg, lot# MON17384 Exp. 12/31/2019, was prompted because a complaint of a sealed bottle labeled as Montelukast 10mg 30 ct found to contain 90 tablets of Losartan Potassium Tablets, USP 50mg
FDA - U.S. Food and Drug Administration
7-9-2018
Human medicines European public assessment report (EPAR): Tovanor Breezhaler, glycopyrronium bromide, Revision: 12, Authorised
Europe - EMA - European Medicines Agency
7-9-2018
Orphan designation: Recombinant human beta-glucuronidase (vestronidase alfa), for the: Treatment of mucopolysaccharidosis type VII (Sly syndrome)
On 21 March 2012, orphan designation (EU/3/12/973) was granted by the European Commission to NDA Regulatory Science Ltd, United Kingdom, for recombinant human beta-glucuronidase for the treatment of mucopolysaccharidosis type VII (Sly syndrome).
Europe - EMA - European Medicines Agency
3-9-2018
Human medicines European public assessment report (EPAR): Bronchitol, mannitol, Revision: 12, Authorised
Europe - EMA - European Medicines Agency
3-9-2018
Human medicines European public assessment report (EPAR): Temozolomide Sun, temozolomide, Revision: 12, Authorised
Europe - EMA - European Medicines Agency
3-9-2018
Human medicines European public assessment report (EPAR): Pergoveris, follitropin alfa / lutropin alfa, Revision: 12, Authorised
Europe - EMA - European Medicines Agency
1-9-2018
Acknowledgement:EFSA wishes to thank the rapporteur Member State Denmark for thepreparatory work on this scientific output.Suggested citation:EFSA (European Food Safety Authority), Brancato A, Brocca D, Carrasco Cabrera L,De Lentdecker C, Erdos
Published on: Fri, 31 Aug 2018 00:00:00 +0200 According to Article 12 of Regulation (EC) No 396/2005, EFSA has reviewed the maximum residue levels (MRLs) currently established at European level for the pesticide active substance napropamide. To assess the occurrence of napropamide residues in plants, processed commodities, rotational crops and livestock, EFSA considered the conclusions derived in the framework of Directive 91/414/EEC as well as the European authorisations reported by Member States (incl...
Europe - EFSA - European Food Safety Authority Publications
1-9-2018
Review of the existing MRLs for fenbuconazole
Published on: Fri, 31 Aug 2018 00:00:00 +0200 According to Article 12 of Regulation (EC) No 396/2005, EFSA has reviewed the maximum residue levels (MRLs) currently established at European level for the pesticide active substance fenbuconazole. To assess the occurrence of fenbuconazole residues in plants, processed commodities, rotational crops and livestock, EFSA considered the conclusions derived in the framework of Directive 91/414/EEC, the MRLs established by the Codex Alimentarius Commission as well...
Europe - EFSA - European Food Safety Authority Publications
30-8-2018
Human medicines European public assessment report (EPAR): Imbruvica, ibrutinib, Revision: 12, Authorised
Europe - EMA - European Medicines Agency
30-8-2018
Grant agreement for piloting the Framework Partnership Agreement between the National data provider organisations in Denmark and EFSA – Final report
Published on: Tue, 07 Aug 2018 00:00:00 +0200 During the project seven standard operating procedures (SOP) were developed for the four data domains (zoonoses, chemical contaminant, pesticide residues and veterinary medical products residues). The SOPs describe 1) How the national governance of risk assessment data is organised, 2) how data are collected and validated before delivering to EFSA covering all four domains, 3) How data is transferred to EFSA, 4) how to respond to EFSA request for clarificati...
Europe - EFSA - European Food Safety Authority Publications
29-8-2018
Product Quest Manufacturing LLC Recalls All Nasal Products and Baby Oral Gels Manufactured at Florida Facility Due to Possible Microbial Contamination
Product Quest Manufacturing (“Product Quest”) announced its voluntary recall of Lot# 173089J of CVS Health 12 Hour Sinus Relief Nasal Mist due to a finding of microbial contamination identified as Pseudomonas aeruginosa.
FDA - U.S. Food and Drug Administration
29-8-2018
Review of the existing maximum residue levels for sintofen according to Article 12 of Regulation (EC) No 396/2005
Published on: Tue, 28 Aug 2018 00:00:00 +0200 According to Article 12 of Regulation (EC) No 396/2005, EFSA has reviewed the maximum residue levels (MRLs) currently established at European level for the pesticide active substance sintofen. To assess the occurrence of sintofen residues in plants, processed commodities, rotational crops and livestock, EFSA considered the conclusions derived in the framework of Commission Regulation (EC) No 33/2008, as well as the European authorisations reported by Member ...
Europe - EFSA - European Food Safety Authority Publications
29-8-2018
Review of the existing maximum residue levels for prochloraz according to Article 12 of Regulation (EC) No 396/2005
Published on: Mon, 27 Aug 2018 00:00:00 +0200 According to Article 12 of Regulation (EC) No 396/2005, EFSA has reviewed the maximum residue levels (MRLs) currently established at European level for the pesticide active substance prochloraz. To assess the occurrence of prochloraz residues in plants, processed commodities, rotational crops and livestock, EFSA considered the conclusions derived in the framework of Directive 91/414/EEC, the MRLs established by the Codex Alimentarius Commission as well as th...
Europe - EFSA - European Food Safety Authority Publications
29-8-2018
Review of the existing maximum residue levels for napropamide according to Article 12 of Regulation (EC) No 396/2005
Published on: Fri, 24 Aug 2018 00:00:00 +0200 According to Article 12 of Regulation (EC) No 396/2005, EFSA has reviewed the maximum residue levels (MRLs) currently established at European level for the pesticide active substance napropamide. To assess the occurrence of napropamide residues in plants, processed commodities, rotational crops and livestock, EFSA considered the conclusions derived in the framework of Directive 91/414/EEC as well as the European authorisations reported by Member States (incl...
Europe - EFSA - European Food Safety Authority Publications
29-8-2018
Review of the existing maximum residue levels for myclobutanil according to Article 12 of Regulation (EC) No 396/2005
Published on: Mon, 13 Aug 2018 00:00:00 +0200 According to Article 12 of Regulation (EC) No 396/2005, EFSA has reviewed the maximum residue levels (MRLs) currently established at European level for the pesticide active substance myclobutanil. To assess the occurrence of myclobutanil residues in plants, processed commodities, rotational crops and livestock, EFSA considered the conclusions derived in the framework of Commission Regulation (EC) No 33/2008, the MRLs established by the Codex Alimentarius Com...
Europe - EFSA - European Food Safety Authority Publications
29-8-2018
Outcome of the public consultation on a draft protocol for the Scientific Opinion on dietary sugars
Published on: Fri, 10 Aug 2018 00:00:00 +0200 The European Food Safety Authority (EFSA) carried out a public consultation to receive input from the scientific community and all interested parties on a draft protocol for the Scientific Opinion on free sugars from all dietary sources, prepared by the EFSA Panel on Dietetic Products, Nutrition and Allergies (NDA Panel), supported by the ad‐hoc Working Group on Sugars. The draft protocol was endorsed by the Panel for public consultation at its plenary meeti...
Europe - EFSA - European Food Safety Authority Publications
29-8-2018
Protocol for the scientific opinion on the Tolerable Upper Intake Level of dietary sugars
Published on: Fri, 10 Aug 2018 00:00:00 +0200 In June 2016, EFSA received a mandate from the national food competent authorities of five European countries (Denmark, Finland, Iceland, Norway and Sweden) to provide a dietary reference value (DRV) for sugars, with particular attention to added sugars. A draft protocol was developed with the aim of defining as much as possible beforehand the strategy that will be applied for collecting data, appraising the relevant evidence, and analysing and integrating t...
Europe - EFSA - European Food Safety Authority Publications
28-8-2018
Accord Healthcare Inc. Issues Voluntary Nationwide Recall of Hydrochlorothiazide Tablets USP 12.5 Mg Due to Labeling Mix-up
A 100 count bottle of Hydrochlorothiazide Tablets USP 12.5 mg has been found to contain 100 Spironolactone Tablets USP 25 mg. Since the individual lot, PW05264, of the product is involved in a potential mix-up of labeling, Accord is recalling this individual lot from the market.
FDA - U.S. Food and Drug Administration
24-8-2018
Human medicines European public assessment report (EPAR): HyQvia, human normal immunoglobulin, Revision: 12, Authorised
Europe - EMA - European Medicines Agency
24-8-2018
Human medicines European public assessment report (EPAR): Vedrop, tocofersolan, Revision: 12, Authorised
Europe - EMA - European Medicines Agency
22-8-2018
Radagast Pet Food Voluntarily Expands Recall to Include Rad Cat Raw Diet Products With Best By Dates of 10/19/18 Through 12/3/19 Due to Potential Health Risk
Radagast Pet Food, Inc. of Portland, OR is expanding its voluntary recall to include an additional quantity of Rad Cat Raw Diet across all varieties with Best By dates of 10/19/18 through 12/3/19 because it has the potential to be contaminated with Listeria monocytogenes. Radagast Pet Food is conducting this voluntary recall out of an abundance of caution because of its strong commitment to food safety and quality.
FDA - U.S. Food and Drug Administration
15-8-2018
Human medicines European public assessment report (EPAR): Pregabalin Pfizer, pregabalin, Revision: 12, Authorised
Europe - EMA - European Medicines Agency
9-8-2018
Human medicines European public assessment report (EPAR): Fampyra, fampridine, Revision: 12, Authorised
Europe - EMA - European Medicines Agency
8-8-2018
Product Quest Manufacturing LLC Issues Voluntary Nationwide Recall of CVS Health 12 Hour Sinus Relief Nasal Mist Due to Microbiological Contamination
Holly Hill, FL, Product Quest Manufacturing (“Product Quest”) is voluntarily recalling Lot# 173089J of CVS Health 12 Hour Sinus Relief Nasal Mist, a clear, colorless liquid, to the consumer level. The product was found to have had microbiological contamination identified as Pseudomonas aeruginosa.
FDA - U.S. Food and Drug Administration
3-8-2018
Human medicines European public assessment report (EPAR): Ameluz, 5-aminolevulinic acid hydrochloride, Revision: 12, Authorised
Europe - EMA - European Medicines Agency
1-8-2018
Human medicines European public assessment report (EPAR): Ceplene, histamine dihydrochloride, Revision: 12, Authorised
Europe - EMA - European Medicines Agency
31-7-2018
UPDATED INFORMATION: September 12, 2018: Meeting of the Pharmacy Compounding Advisory Committee Meeting Announcement
FDA - U.S. Food and Drug Administration
30-7-2018
Human medicines European public assessment report (EPAR): Remsima, infliximab, Revision: 12, Authorised
Europe - EMA - European Medicines Agency
20-7-2018
Human medicines European public assessment report (EPAR): Imnovid (previously Pomalidomide Celgene), pomalidomide, Revision: 12, Authorised
Europe - EMA - European Medicines Agency
19-7-2018
July 18, 2018: Medical Device Maker AngioDynamics Agrees to Pay $12.5 Million to Resolve False Claims Act Allegations
July 18, 2018: Medical Device Maker AngioDynamics Agrees to Pay $12.5 Million to Resolve False Claims Act Allegations
FDA - U.S. Food and Drug Administration
19-7-2018
Human medicines European public assessment report (EPAR): Caprelsa, vandetanib, Revision: 12, Authorised
Europe - EMA - European Medicines Agency
18-7-2018
Human medicines European public assessment report (EPAR): Iressa, gefitinib, Revision: 12, Authorised
Europe - EMA - European Medicines Agency
18-7-2018
Human medicines European public assessment report (EPAR): Kyprolis, carfilzomib, Revision: 12, Authorised
Europe - EMA - European Medicines Agency
18-7-2018
Orphan designation: Gevokizumab, for the: Treatment of chronic non-infectious uveitis
On 12 March 2013, orphan designation (EU/3/13/1111) was granted by the European Commission to Les Laboratoires Servier, France, for gevokizumab for the treatment of chronic non-infectious uveitis.
Europe - EMA - European Medicines Agency
17-7-2018
Veterinary medicine European public assessment report (EPAR): Zolvix, monepantel, Revision: 12, Authorised
Europe - EMA - European Medicines Agency
17-7-2018
The PictSweet Company Recalls 12 Ounce Steam’ables Baby Brussel Sprouts for Undeclared Milk and Soy Allergens
Bells, TN – The Pictsweet Company has recalled 960 cases of Pictsweet Farms 12-ounce Steam’ables Baby Brussels Sprouts because they may contain undeclared milk and soy allergens. People who have an allergy or severe sensitivity to milk or soy may run the risk of serious allergic reaction if they consume this product.
FDA - U.S. Food and Drug Administration
16-7-2018
Human medicines European public assessment report (EPAR): Pantozol Control, pantoprazole, Revision: 12, Authorised
Europe - EMA - European Medicines Agency
1-10-2018
EU/3/05/328 (Celgene Europe B.V.)
EU/3/05/328 (Active substance: (E)-(1S,4S,10S,21R)-7-[(Z)-ethylidene]-4,21-diisopropyl-2-oxa-12,13-dithia-5,8,20,23- tetraazabicyclo[8.7.6]tricos-16-ene-3,6,9,19,22-pentone) - Transfer of orphan designation - Commission Decision (2018)6434 of Mon, 01 Oct 2018 European Medicines Agency (EMA) procedure number: EMA/OD/056/05/T/03
Europe -DG Health and Food Safety
1-10-2018
EU/3/05/279 (Celgene Europe B.V.)
EU/3/05/279 (Active substance: (E)-(1S,4S,10S,21R)-7-[(Z)-ethylidene]-4,21-diisopropyl-2-oxa-12,13-dithia-5,8,20,23- tetraazabicyclo[8.7.6]tricos-16-ene-3,6,9,19,22-pentone) - Transfer of orphan designation - Commission Decision (2018)6433 of Mon, 01 Oct 2018 European Medicines Agency (EMA) procedure number: EMA/OD/001/05/T/03
Europe -DG Health and Food Safety
26-9-2018
Today, Wednesday, September 26th 2018 at 12 pm EST is the last day that the #FDA will be soliciting site visit proposals for the 2018 Experiential Learning Program. Click the link to find more about the program & submit your application: http://go.usa.g
Today, Wednesday, September 26th 2018 at 12 pm EST is the last day that the #FDA will be soliciting site visit proposals for the 2018 Experiential Learning Program. Click the link to find more about the program & submit your application: http://go.usa.gov/xPrum #MedicalDevice pic.twitter.com/Zsmq00NCdd
FDA - U.S. Food and Drug Administration
19-9-2018
Reminder: #FDA site visit proposal solicitation period for the 2018 Experiential Learning Program is currently OPEN through Wednesday, 9/26/18 @ 12 pm EST. Click the link to find more about the program & to submit your application https://go.usa.gov/x
Reminder: #FDA site visit proposal solicitation period for the 2018 Experiential Learning Program is currently OPEN through Wednesday, 9/26/18 @ 12 pm EST. Click the link to find more about the program & to submit your application https://go.usa.gov/xPrum #MedicalDevice pic.twitter.com/FN1mNN65dD
FDA - U.S. Food and Drug Administration
19-9-2018
Memantine Mylan (Mylan S.A.S.)
Memantine Mylan (Active substance: Memantine) - Centralised - Transfer Marketing Authorisation Holder - Commission Decision (2018)5972 of Wed, 19 Sep 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/2660/T/12
Europe -DG Health and Food Safety
14-9-2018
Agenda: Agenda - CAT agenda of the 12-14 September 2018 meeting
Europe - EMA - European Medicines Agency
12-9-2018
The FDA site visit proposal solicitation period for the 2018 Experiential Learning Program is currently OPEN through Wednesday, September 26th 2018 12 pm EST. Click the link to find more about the program & to submit your application https://go.usa.gov/x
The FDA site visit proposal solicitation period for the 2018 Experiential Learning Program is currently OPEN through Wednesday, September 26th 2018 12 pm EST. Click the link to find more about the program & to submit your application https://go.usa.gov/xPrum #FDA #MedicalDevice pic.twitter.com/Kyo5z44Os4
FDA - U.S. Food and Drug Administration
12-9-2018
ADCETRIS (Takeda Pharma A/S)
ADCETRIS (Active substance: Brentuximab vedotin) - Centralised - Annual renewal - Commission Decision (2018)5973 of Wed, 12 Sep 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/2455/R/58
Europe -DG Health and Food Safety
11-9-2018
Focus group meeting on dose optimisation of established veterinary antibiotics in the context of summary of product characteristics harmonisation, European Medicines Agency, London, UK, From: 12-Oct-2018, To: 12-Oct-2018
This meeting will allow a direct exchange of views between the Agency’s working party and stakeholders on its draft reflection paper on dose optimisation of established veterinary antibiotics in the context of summary of product characteristics (SPC) harmonisation (EMA/CVMP/849775/2017). It complements the public consultation on this reflection paper ending on 31 January 2019. The reflection paper follows considerations in the report on a pilot project that aimed to develop and test non-experimental appr...
Europe - EMA - European Medicines Agency
5-9-2018
The FDA's site visit proposal solicitation period for the 2018 Experiential Learning Program is currently OPEN through Wednesday, September 26th 2018 at 12 pm EST. Click the link to find more about the program and to submit your application: https://go.u
The FDA's site visit proposal solicitation period for the 2018 Experiential Learning Program is currently OPEN through Wednesday, September 26th 2018 at 12 pm EST. Click the link to find more about the program and to submit your application: https://go.usa.gov/xPcpn #MedicalDevice
FDA - U.S. Food and Drug Administration
7-8-2018
ACMD meeting statement, Meeting 40, 12 April 2018
Advisory Committee on Medical Devices meeting statement
Therapeutic Goods Administration - Australia
27-7-2018
EU/3/12/1097 (Celgene Europe B.V.)
EU/3/12/1097 (Active substance: Lenalidomide) - Transfer of orphan designation - Commission Decision (2018)5043 of Fri, 27 Jul 2018 European Medicines Agency (EMA) procedure number: EMA/OD/158/12/T/01
Europe -DG Health and Food Safety
27-7-2018
EU/3/12/1091 (bluebird bio (Germany) GmbH)
EU/3/12/1091 (Active substance: Autologous CD34+ haematopoietic stem cells transduced with lentiviral vector encoding the human betaA-T87Q-globin gene) - Transfer of orphan designation - Commission Decision (2018)5032 of Fri, 27 Jul 2018 European Medicines Agency (EMA) procedure number: EMA/OD/146/12/T/01
Europe -DG Health and Food Safety
27-7-2018
EU/3/12/1003 (bluebird bio (Germany) GmbH)
EU/3/12/1003 (Active substance: Autologous haematopoietic stem cells transduced with lentiviral vector Lenti-D encoding the human ABCD1 cDNA) - Transfer of orphan designation - Commission Decision (2018)5033 of Fri, 27 Jul 2018 European Medicines Agency (EMA) procedure number: EMA/OD/009/12/T/01
Europe -DG Health and Food Safety
27-7-2018
EU/3/13/1127 (Pfizer Europe MA EEIG)
EU/3/13/1127 (Active substance: Inotuzumab ozogamicin) - Transfer of orphan designation - Commission Decision (2018)5046 of Fri, 27 Jul 2018 European Medicines Agency (EMA) procedure number: EMA/OD/194/12/T/01
Europe -DG Health and Food Safety
27-7-2018
EU/3/12/998 (Orchard Therapeutics Ltd)
EU/3/12/998 (Active substance: Autologous CD34+ cells transfected with lentiviral vector containing the Wiskott-Aldrich syndrome protein gene) - Transfer of orphan designation - Commission Decision (2018)5062 of Fri, 27 Jul 2018 European Medicines Agency (EMA) procedure number: EMA/OD/014/12/T/02
Europe -DG Health and Food Safety
27-7-2018
EU/3/12/1066 (Pfizer Europe MA EEIG)
EU/3/12/1066 (Active substance: tafamidis) - Transfer of orphan designation - Commission Decision (2018)5066 of Fri, 27 Jul 2018 European Medicines Agency (EMA) procedure number: EMA/OD/115/12/T/01
Europe -DG Health and Food Safety
22-7-2018
On Friday, Bayer said the permanent birth control device Essure would no longer be sold or distributed in the US for commercial reasons after 12/31/18. This came after FDA’s patient safety action in April restricting sale and distribution of the device an
On Friday, Bayer said the permanent birth control device Essure would no longer be sold or distributed in the US for commercial reasons after 12/31/18. This came after FDA’s patient safety action in April restricting sale and distribution of the device and earlier agency actions
FDA - U.S. Food and Drug Administration
19-7-2018
EU/3/12/1083 (Global Regulatory Limited)
EU/3/12/1083 (Active substance: Humanised single chain monoclonal antibody against CD37) - Transfer of orphan designation - Commission Decision (2018)4839 of Thu, 19 Jul 2018 European Medicines Agency (EMA) procedure number: EMA/OD/128/12/T/02
Europe -DG Health and Food Safety